# Long-Term Follow-up Study

> **NCT05332054** · — · ENROLLING_BY_INVITATION · sponsor: **Caribou Biosciences, Inc.** · enrollment: 150 (estimated)

## Conditions studied

- Lymphoma, Non-Hodgkin
- Relapsed Non-Hodgkin Lymphoma
- Refractory B-Cell Non-Hodgkin Lymphoma
- Non-Hodgkin Lymphoma
- Lymphoma
- B Cell Lymphoma
- B-Cell Non-Hodgkin's Lymphoma
- Hematologic Malignancy
- Relapsed/Refractory Multiple Myeloma
- Relapsed/Refractory Acute Myeloid Leukemia

## Interventions

- **BIOLOGICAL:** Caribou-sponsored investigational therapy

## Key facts

- **NCT ID:** NCT05332054
- **Lead sponsor:** Caribou Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-03-16
- **Primary completion:** 2041-12
- **Final completion:** 2041-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05332054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05332054, "Long-Term Follow-up Study". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05332054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*